(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -1.8% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 282.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.78%.
Rockwell Medical's revenue in 2025 is $75,577,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,711,478,831, with the lowest RMTI revenue forecast at $2,590,346,932, and the highest RMTI revenue forecast at $2,807,036,688. On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $2,931,557,442, with the lowest RMTI revenue forecast at $2,710,139,050, and the highest RMTI revenue forecast at $3,131,854,592.
In 2027, RMTI is forecast to generate $2,961,820,714 in revenue, with the lowest revenue forecast at $2,845,653,884 and the highest revenue forecast at $3,048,906,432.